WALGREENS SHAREHOLDER ALERT: Levi & Korsinsky Launches an Investigation into
Claims of Breaches of Fiduciary Duty Against The Board of Directors of
NEW YORK -- August 15, 2013
Levi & Korsinsky is investigating potential claims of against the board of
directors of Walgreen Co. (“Walgreen” or the “Company”) (NYSE: WAG).
For more information, click here: http://zlk.9nl.com/walgreen-wag/.
On June 11, 2013, Walgreen entered into a settlement agreement with the Drug
Enforcement Administration in connection with civil charges that the Company
had practiced improper distribution of prescription painkillers. Mark R.
Trouville, Special Agent of the DEA’s Miami field office, called Walgreen’s
actions “a clear example of inexcusable corporate conduct that existed only
for greed and profit.” Under the settlement, Walgreen agreed to an $80 million
payout that is expected to negatively impact Walgreen stock price by 4 to 6
cents per share in the third quarter of 2013. The Company is also required to
surrender its DEA registrations at six of its more than 800 Florida pharmacies
until May 2014 and at a Florida distribution center until September 2014.
If you own Walgreen stock and wish to obtain additional information about the
investigation and your legal rights, please contact Joseph E. Levi, Esq.
either via email at email@example.com or by telephone at (877) 363-5972, or visit
Levi & Korsinsky is a national firm with offices in New York, New Jersey, and
Washington D.C. The firm has extensive expertise in prosecuting securities
litigation involving financial fraud, representing investors throughout the
nation in securities and shareholder lawsuits. Attorney advertising. Prior
results do not guarantee similar outcomes.
Levi & Korsinsky, LLP
Joseph Levi, Esq.
Eduard Korsinsky, Esq.
Toll Free: 877-363-5972
Press spacebar to pause and continue. Press esc to stop.